|
Direct-to-consumer advertising (DTC advertising) sometimes refers to the marketing of pharmaceutical products but applies in other areas as well. This form of advertising is directed toward patients, rather than healthcare professionals. The Food and Drug Administration is responsible for regulating DTC advertising in the United States. The FDA’s latest version of guidelines, though still in draft form, for pharmaceutical drug advertising was updated in 2009.〔http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm064956.htm〕 Forms of DTC advertising include TV, print, radio and other mass and social media. There are ethical and regulatory concerns regarding DTC advertising, specifically the extent to which these ads may unduly influence the prescribing of the prescription medicines based on consumer demands when, in some cases, they may not be medically necessary. == Nations permitting DTC == To date three nations permit DTC in the pharmaceutical industry (Nation, year of legalization) * New Zealand (1981) * United States (1997) * Brazil (2008) - In 2008 a new resolution from ANVISA (Control Agency for Sanitary Vigilance)- Resolution 96 from December 17 was released, with focus on medication advertisement. It allows direct-to-consumer advertising, with restrictions on the type of drug and words and images that can be used, among other things.〔 http://portal.anvisa.gov.br/wps/wcm/connect/076f3080492dd932afe8bf14d16287af/Legislacao_Propaganda_Consolidada_marco_2011.pdf?MOD=AJPERES〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Direct-to-consumer advertising」の詳細全文を読む スポンサード リンク
|